Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 9, 2024
Reporting Period: Three months ended December 31, 2023
Context: The Company filed this report to announce financial results for the quarter ended December 31, 2023, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) for detailed figures. The text itself does not contain specific numerical values for the following metrics:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific data to compare current period performance against the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for variance analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q4 2023 results but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K. The filing includes a standard disclaimer that the information is not "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 9, 2024) for actual revenue, net income, and cash flow figures.
- Verify the Company's status as an Emerging Growth Company (indicated as checked in the filing) and its implications for financial reporting standards.
- Confirm the trading symbol INBS on The Nasdaq Stock Market LLC.
- Check for any subsequent filings that may incorporate the press release by reference.